RSS Patient Assistance – FLASCO

  • Boehringer Ingelheim Patient Assistance Program August 14, 2018
    Boehringer Ingelheim is on a mission to improve lives around the world. We do this by developing innovative medicines and helping patients gain access to them – wherever they may be – and by supporting innovative programs that help ensure the health of individuals and communities in this and future generations. The post Boehringer Ingelheim […]
  • Taiho Oncology Patient Assistant Program December 12, 2016
    Taiho Oncology Patient Assistant Program (Taiho Oncology PAP) will become effective Jan 1, 2017. A Medicare Part D patient applying for the Taiho Oncology Patient Assistance Program (PAP) in 2017 who falls below 150% of the Federal Poverty Level, will first need to apply for the Medicare Part D Low-Income Subsidy (LIS) program. Patients currently... […]
  • How Myriad’s myPlan Addresses the Risk of Recurrence in Lung Cancer October 20, 2016
    Benjamin P. Levy, MD, assistant professor at the Icahn School of Medicine, medical director of the Thoracic Oncology Program, Mount Sinai Health Systems, and associate director of the Cancer Clinical Trials Office at Mount Sinai Hospital in New York, discusses how Myriad’s myPlan addresses the risk of recurrence in lung cancer. The post How Myriad’s […]
  • Xtandi Resources: Customize A Selection of Advanced Prostate Cancer Resources October 19, 2016
    The post Xtandi Resources: Customize A Selection of Advanced Prostate Cancer Resources appeared first on FLASCO.
  • Keytruda (pembrolizumab) Patient Support Program May 13, 2016
    The KEY+YOU Support Program provides patients and their caregivers with support 24/7 throughout their treatment with KEYTRUDA® (pembrolizumab) injection 100 mg. The program gives patients and caregivers the option of talking with an experienced nurse who offers support by telephone and/or receiving resources by e-mail. KEY+YOU nurses can provide general information about KEYTRUDA. Enrollees are... […]
  • NOW APPROVED COTELLIC in combination with ZELBORAF® (vemurafenib) May 4, 2016
    Genentech BioOncology® Access Solutions and Patient Partners™ Genentech BioOncology Access Solutions provides reliable, effective access and reimbursement services to assist your patients and practice. We can help address the needs of each patient’s coverage scenario. Available assistance for your eligible patients*: Patient situation Patient assistance option Insurance status of potentially eligible patients † Genentech does... […]
  • Tarceva Patient Support Program March 8, 2016
    The Tarceva Patient Support Program offers information and resources that can help you throughout treatment. When you enroll, you will receive: A Tarceva Starter Kit Eating Well Through Cancer cookbook* 24-hour phone support, 7 days a week, from our oncology nurse experts Emails at key times to help you stay on track with your treatment,... […]
  • EISAI Halaven Savings Program November 12, 2015
    [su_button url=”http://www.eisaireimbursement.com/halaven/savingsoffers.aspx” target=”blank” style=”flat” background=”#1a00ff” color=”#fafafa” size=”8″ wide=”yes” center=”yes” icon=”icon: arrow-circle-right” icon_color=”#ffffff” text_shadow=”0px 0px 0px #fafafa”]Click here to go to the Halaven Savings Program website[/su_button] The post EISAI Halaven Savings Program appeared first on FLASCO.
  • Genentech Breast Cancer Patient Resources October 20, 2015
    her-bca1 For your practice and your patients- Support for navigating the breast cancer journey Genentech provides an array of resources, tools, and in-office presentations designed specifically for patients with breast cancer and their healthcare teams For your patients 4HER PATIENT SUPPORT APP • A free app from Genentech that supports HER2+ breast cancer patients with information about breast cancer,... […]
  • Boehringer Ingelheim – Biomarker Testing September 4, 2015
    Boehringer Ingelheim has a website that provides information to assist with biomarker testing on Advanced Non Small Cell Lung Cancer.  Explore “Let’s Test” for a wealth of resources.  In the age of personalized medicine, oncologists can routinely order biomarker tests for their patients with advanced NSCLC—and use the results to consider more tailored treatment. Treatment decisions... […]